Abstract
Neuroimaging is paramount in the medical management of glial tumours. Through various imaging modalities, radiologists provide essential information about tumours and guide treatments. Alongside tumour location and complications, imaging is also able to give a strong indication of tumour grade, a key factor in determining treatment pathways. Once a diagnosis has been established, neuroimaging is then often relied on for monitoring low-grade tumours for transformation as well as post-treatment follow-up of higher-grade tumours.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Watson SJ, Jones AL, Oatway WB, Hughes JS. Ionising radiation exposure of the UK population: 2005 review. Didcot: Health Protection Agency; 2005.
Drain KL, Volcheck GW. Preventing and managing drug-induced anaphylaxis. Drug Saf. 2001;24(11):843–53.
Katzberg RW, Newhouse JH. Intravenous contrast medium–induced nephrotoxicity: is the medical risk really as great as we have come to believe? Radiology. 2010;256:21–8.
Lin ZX. Glioma-related edema: new insight into molecular mechanisms and their clinical implications. Chin J Cancer. 2013;32(1):49.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rees, E., Das, T. (2019). Neuroimaging. In: Oberg, I. (eds) Management of Adult Glioma in Nursing Practice. Springer, Cham. https://doi.org/10.1007/978-3-319-76747-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-76747-5_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-76746-8
Online ISBN: 978-3-319-76747-5
eBook Packages: MedicineMedicine (R0)